Home・Aktien・GE HealthCare Technologies

GE HealthCare Technologies

Geschlossen

BrancheGesundheitswesen

70.23 1.49

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

68.98

Max

70.34

Schlüsselkennzahlen
By Trading Economics
Einkommen	163M 574M
Verkäufe	164M 5.3B
KGV Branchendurchschnitt	16.067 68.51
EPS	1.13
Dividendenrendite	0.21
Gewinnspanne	10.84
Angestellte	54,000
EBITDA	52M 807M

Empfehlungen
By TipRanks
Empfehlungen	Buy
12-Monats-Prognose	+12.54% upside

Dividenden
By Acuity
Dividendenrendite Branchendurchschnitt	0.21% 2.29%
Nächstes Ergebnis	28. Okt. 2026
Nächste Dividendenausschüttung	14. Aug. 2026
Nächstes Ex-Dividendendatum	23. Okt. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	3.9B 32B
Vorheriger Eröffnungskurs	68.74
Vorheriger Schlusskurs	70.23

Nachrichtenstimmung

By Acuity

92%

10 / 340 Ranking in Healthcare

GE HealthCare Technologies Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Peer-Vergleich

Kursveränderung

GE HealthCare Technologies Prognose

Kursziel

By TipRanks

12.54% Vorteil

12-Monats-Prognose

Durchschnitt 79.07 USD 12.54%

Hoch 92 USD

Tief 70 USD

Basierend auf 14 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für GE HealthCare Technologies – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

14 ratings

Buy

Halten

Sell

Basierend auf 14 Analysten, die in den letzten 3 Monaten Aktienbewertungen für GE HealthCare Technologies – Dist abgegeben haben.

Stimmung

By Acuity

10 / 340 Ranking in Gesundheitswesen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über GE HealthCare Technologies

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The Ultrasound segment provides medical devices and solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring solutions, anesthesia delivery and respiratory care products, electrocardiogram solutions, maternal infant care products, and consumables and services. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. It has an AI collaboration with Mass General Brigham. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.